Domov › Melanóm › Pennsylvania › Philadelphia
Klinické štúdie Melanóm v meste Philadelphia, PA
23 štúdií pre Melanóm hľadá účastníkov v zariadeniach v meste Philadelphia a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 míľ odtiaľ
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Prebieha náborFáza 3
- Fox Chase Cancer Center, Philadelphia
DESTINY-PANTUMOUR04
Prebieha náborObservačná štúdia
- Research Site, Philadelphia
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Prebieha náborFáza 2
- Thomas Jefferson University Hospital, Philadelphia
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Prebieha náborFáza 2
- Children's Hospital of Philadelphia, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · 25 míľ odtiaľ
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Prebieha náborFáza 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 míľ odtiaľ
- a 3 ďalších
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Prebieha náborFáza 1/2
- University of Pennsylvania, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Prebieha náborObservačná štúdia
- University of Pennsylvania, Philadelphia
Project: Every Child for Younger Patients With Cancer
Prebieha náborObservačná štúdia
- Drexel University School of Medicine, Philadelphia
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- a 1 ďalších
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Prebieha náborFáza 1/2
- Children's Hospital of Philadelphia, Philadelphia
Tebentafusp-tebn With LDT in Metastatic UM
Prebieha náborFáza 1/2
- Thomas Jefferson University, Philadelphia
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Prebieha náborFáza 1/2
- Fox Chase Cancer Center, Philadelphia
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Prebieha náborFáza 1/2
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
Prebieha náborSkorá fáza 1
- Fox Chase Cancer Center, Philadelphia
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Prebieha náborFáza 1/2
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Prebieha náborFáza 3
- Jefferson Health Honickman Center, Philadelphia
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Prebieha náborFáza 2/3
- UPenn, Philadelphia
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Prebieha náborFáza 2/3
- Thomas Jefferson University, Philadelphia
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Prebieha náborFáza 3
- Thomas Jefferson University Medical Oncology Clinic, Philadelphia
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Prebieha náborFáza 3
- Fox Chase Cancer Center 333 Cottman Avenue, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Philadelphia
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Prebieha nábor
- University of Pennsylvania, Philadelphia
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Prebieha nábor
- Fox Chase Cancer Center, Philadelphia
Štúdie Melanóm v iných mestách
- Houston, TX59 štúdií
- New York City, NY38 štúdií
- Los Angeles, CA34 štúdií
- Nashville, TN33 štúdií
- Pittsburgh, PA31 štúdií
- Boston, MA26 štúdií
- San Francisco, CA22 štúdií
- Columbus, OH21 štúdií
- Durham, NC21 štúdií
- Atlanta, GA21 štúdií
- Salt Lake City, UT21 štúdií
- St. Louis, MO21 štúdií
Iné štúdie v Philadelphia
- Rakovina (všetky typy)59 štúdií
- Rakovina prsníka56 štúdií
- Nemalobunkový karcinóm pľúc51 štúdií
- Metastatická rakovina46 štúdií
- Rakovina prostaty44 štúdií
- Kolorektálny karcinóm44 štúdií
- Rakovina vaječníkov44 štúdií
- Rakovina pľúc36 štúdií
- Akútna myeloidná leukémia34 štúdií
- Srdcové zlyhanie31 štúdií
- Rakovina endometria28 štúdií
- Depresia26 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.